1 option
Photo Acoustic and Optical Coherence Tomography Imaging, Volume 1 : Diabetic Retinopathy.
- Format:
- Book
- Author/Creator:
- El-Baz, Ayman.
- Series:
- IOP Ebooks Series
- Language:
- English
- Subjects (All):
- Diabetic retinopathy.
- Optical coherence tomography.
- Physical Description:
- 1 online resource (336 pages)
- Edition:
- 1st ed.
- Place of Publication:
- Bristol : Institute of Physics Publishing, 2024.
- Summary:
- The book focuses on major trends and challenges in the area of using OCT imaging for the diagnosis of retinal diseases; and presents work aimed to identify new techniques and their use in biomedical analysis.
- Contents:
- Intro
- <
- named-book-part-body&
- #62
- p&
- This book covers the state-of-the-art techniques of optical coherence tomography (OCT) imaging for the diagnosis of retinal diseases. Clinical disorders of the retina have been attracting the attention of researchers, aiming at reducing the blindness rate. This includes uveitis, diabetic retinopathy, macular edema, endophthalmitis, proliferative retinopathy, age-related macular degeneration and glaucoma. Currently, most ophthalmologists perform diagnosis by visua
- Acknowledgements
- Editor biographies
- Ayman El-Baz
- Jasjit S Suri
- List of contributors
- Chapter Computerized tool for the automatic segmentation of DRT edemas using OCT scans
- 1.1 Introduction
- 1.2 Computational identification and segmentation of DRT edemas
- 1.2.1 Identification of the region of interest
- 1.2.2 DRT segmentation
- 1.2.3 Post-processing
- 1.3 Results and discussion
- 1.4 Conclusions
- Acknowledgments
- References
- Chapter Recent developments in optical coherence tomography angiography imaging for the diagnosis and assessment of diabetic retinopathy
- 2.1 Introduction
- 2.1.1 Diabetic retinopathy
- 2.1.2 Diagnostic techniques for screening DR
- 2.2 Optical properties of human eye tissue
- 2.3 OCT technique
- 2.3.1 Basic principle
- 2.3.2 Visible and NIR light sources used in OCT systems
- 2.3.3 Different types of OCT systems
- 2.4 Milestones in the advancement of OCT in ophthalmology
- 2.5 OCT-A technique
- 2.5.1 Principle of OCT-A technique
- 2.5.2 Assessment of various pathological conditions related to DR using OCT-A
- 2.5.3 Advancements in the OCT-A imaging modalities
- 2.5.4 Challenges of OCT-A imaging technique
- 2.5.5 Algorithms used in OCT-A imaging for artifact removal
- 2.5.6 Application of deep learning in OCT-A imaging
- 2.6 Conclusion.
- References
- Chapter Multimodal photoacoustic microscopy, optical coherence tomography, and fluorescence microscopy molecular retinal imaging in health and disease
- 3.1 Introduction
- 3.2 Fluorescence imaging
- 3.2.1 Fluorescein angiography
- 3.2.2 Indocyanine green angiography
- 3.2.3 Advantages and limitations
- 3.3 Optical coherence tomography (OCT)
- 3.3.1 Basic principle of OCT
- 3.3.2 Resolution and image dimensions
- 3.3.3 Advantages and limitations
- 3.4 Photoacoustic imaging of the eye
- 3.4.1 Principle of photoacoustic microscopy
- 3.4.2 Requirement for PAM Imaging in the retina
- 3.4.3 Multimodal PAM, OCT, and FM imaging
- 3.4.4 Evaluation of retinal vasculature network and layers using multimodal imaging
- 3.5 Conclusions
- Chapter OCT-Leakage: non-invasive identification and measurement of abnormal retinal fluid
- 4.1 Introduction
- 4.2 OCT-Leakage: analysis of retinal extracellular fluid
- 4.3 Agreement between OCT-Leakage and fluorescein angiography to identify sites of alteration of blood-retinal barrier
- 4.4 Characterization of progression of macular edema
- 4.5 OCT-Leakage to identify and monitor abnormal retinal fluid in treatment of diabetic macular edema
- 4.6 Conclusion
- Chapter Comparison of ocular ultrasound with optical coherence tomography in the evaluation of diabetic retinopathy
- 5.1 Introduction
- 5.2 Technical differences
- 5.3 Clinical applications in diabetic retinopathy
- 5.3.1 Posterior vitreous detachment and vitreoschisis
- 5.3.2 Tractional retinal detachment
- 5.3.3 Vitreous hemorrhage
- 5.3.4 Axial length measurement
- 5.3.5 Measuring blood perfusion
- 5.3.6 Patient collaboration
- 5.4 Conclusion
- Chapter Optical coherence tomography biomarkers in diabetic macular edema
- 6.1 Introduction.
- 6.2 Retinal thickness and macular volume
- 6.3 Subfoveal choroidal thickness
- 6.4 Vitreomacular interface
- 6.4.1 Vitreomacular adhesion and posterior vitreous detachment
- 6.4.2 Epiretinal membrane and vitreomacular traction
- 6.5 Disorganization of the inner retinal layers
- 6.6 External limiting membrane and ellipsoid zone
- 6.7 Hyperreflective foci
- 6.7.1 Clinical and prognostic implications of hyperreflective foci in diabetic macular edema
- 6.8 Intraretinal cystoid spaces and bridging retinal processes
- 6.9 Subfoveal neurosensory detachment
- 6.10 Conclusion
- Chapter Optical coherence tomography biomarkers in diabetic macular edema: OCT biomarkers in diabetic macular edema
- 7.1 Introduction
- 7.2 OCT biomarkers of the vitreoretinal interface
- 7.3 OCT biomarkers of the retina
- 7.3.1 Central macular thickness
- 7.3.2 Central macular volume
- 7.3.3 Intraretinal cystoid spaces
- 7.3.4 Disorganization of the retinal inner layers
- 7.3.5 Hyperreflective foci
- 7.3.6 Subfoveal neuroretinal detachment
- 7.3.7 Ellipsoid zone disruption
- 7.3.8 External limiting membrane disruption
- 7.3.9 Retinal pigment epithelium status
- 7.4 OCT biomarkers of the choroid
- 7.4.1 Subfoveal choroidal thickness
- 7.4.2 Choroidal vascularity index
- 7.4.3 Choroidal hyperreflective foci
- 7.5 Conclusion
- Financial disclosure
- Chapter Optical coherence tomography and OCTA for the diagnosis of diabetic macular edema
- 8.1 Introduction to DME
- 8.2 Development/history of OCT use in DME
- 8.3 Pathology and mechanism of OCT findings in DME
- 8.4 Findings identified on OCT in the diagnosis of DME
- 8.5 Classification and grading of OCT findings in DME
- 8.6 Introduction and development of OCTA in the diagnosis of DME
- 8.7 Pathology and mechanism of OCTA findings in DME
- References.
- Chapter Optical coherence tomography and OCTA for the treatment of diabetic macular edema
- 9.1 Introduction
- 9.2 Preventative measures for DR and DME
- 9.3 Treatment options for DR and DME
- 9.3.1 Treatment options
- 9.4 Monitoring treatment response with OCT
- 9.5 Limitations of OCT in DME
- 9.6 Machine learning prospects of OCT in DME
- 9.7 Future directions of OCT in DME
- 9.8 Limitations of OCTA in DME
- 9.9 Future directions of OCTA in DME
- Chapter On the eye diseases diagnosis using OCT and fundus imaging techniques
- 10.1 Introduction
- 10.2 Fundus camera and various modes of fundus examination
- 10.2.1 Colour fundus photography
- 10.2.2 Angiography fundus image
- 10.2.3 Ultra-wide field fundus image
- 10.2.4 Smartphone-based fundus imaging
- 10.3 Optical coherence tomography
- 10.3.1 Time domain OCT (TD-OCT)
- 10.3.2 Fourier domain OCT (FD-OCT)
- 10.3.3 Swept-source OCT
- 10.4 Comparison between fundus and OCT imaging technique
- 10.5 Fundus and OCT image-based diagnosis of various eye diseases
- 10.5.1 Diabetic retinopathy screening
- 10.5.2 Glaucoma screening
- 10.5.3 Macular oedema screening
- 10.5.4 Macular degeneration screening
- 10.6 Biomarkers associated with fundus and OCT
- 10.7 Details on publicly available retinal and OCT image datasets for research
- 10.8 Recent advancements in commercially available fundus and OCT cameras
- 10.9 Conclusion
- Chapter Optical coherence tomography and optical coherence tomography angiography biomarkers of diabetic macular edema
- 11.1 Introduction
- 11.2 OCT biomarkers of diabetic macular edema
- 11.2.1 Retinal thickness
- 11.2.2 Retinal volume
- 11.2.3 Intraretinal fluid (IRF)
- 11.2.4 Subretinal fluid (SRF)
- 11.2.5 Integrity of the photoreceptor inner segment/outer segment (IS/OS) junction.
- 11.2.6 Disorganization of retinal inner layers
- 11.2.7 Hyperreflective foci
- 11.2.8 Vitreoretinal traction
- 11.2.9 Choroidal thickness, vascularity, and reflectivity
- 11.2.10 Optical reflectivity of intraretinal fluid
- 11.3 OCTA biomarkers of diabetes mellitus
- 11.3.1 Retinal vascular density and blood flow
- 11.3.2 Peripheral findings in wide field OCT and OCTA as biomarkers of DR
- 11.4 Systemic implications of local biomarkers
- 11.5 Future applications
- Chapter Early identification of diabetic retinopathy through a computer-assisted diagnostic system and a higher-order spatial appearance model of 3D-OCT
- 12.1 Introduction
- 12.1.1 Related work
- 12.2 Computer aided diagnosis system
- 12.2.1 OCT volume segmentation
- 12.2.2 Feature extraction
- 12.2.3 Classification system
- 12.3 Experimental results
- 12.4 Conclusions and future work
- Chapter Prevention of age-related macular degeneration disease: current strategies and future directions
- 13.1 Introduction
- 13.2 The different grades of AMD
- 13.2.1 Dry AMD
- 13.2.2 Wet AMD
- 13.3 The image modalities used for AMD classification
- 13.3.1 Fundus image
- 13.3.2 Optical coherence tomography (OCT)
- 13.4 The pathologies associated with AMD
- 13.4.1 Drusen
- 13.4.2 Geographic atrophy
- 13.4.3 Neovascular AMD
- 13.5 Methods
- 13.5.1 CAD approaches for AMD grading
- 13.6 Discussion and future direction
- 13.7 Conclusion
- Chapter Optical coherence tomography in diabetic retinopathy: a review in application of artificial intelligence
- 14.1 Introduction to optical coherence tomography
- 14.1.1 Advantages of the optical coherence tomography
- 14.1.2 Clinical signs of diabetic retinopathy in the optical coherence tomography
- 14.1.3 Related conventional works
- 14.2 Introduction to artificial intelligence.
- 14.2.1 The advantages of deep learning compared with traditional machine learning.
- Notes:
- Description based on publisher supplied metadata and other sources.
- Part of the metadata in this record was created by AI, based on the text of the resource.
- ISBN:
- 9780750343282
- 0750343281
- OCLC:
- 1429739364
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.